hydrochloric acid 🐶 Veterinary Use | Indications/Contra | FAERs-F | FAERs-M | Orange Bk | BioActivity |
| Stem definition | Drug id | CAS RN |
|---|---|---|
| 4568 | 7647-01-0 |
Description:
| Molecule | Description |
|---|---|
|
Synonyms:
|
A strong corrosive acid that is commonly used as a laboratory reagent. It is formed by dissolving hydrogen chloride in water. GASTRIC ACID is the hydrochloric acid component of GASTRIC JUICE.
|
Drug dosage:
None
ADMET properties:
None
Approvals:
None
FDA Adverse Event Reporting System (Female)
None
FDA Adverse Event Reporting System (Male)
| MedDRA adverse event term | Likelihood ratio | Likelihood ratio threshold | Patients taking drug having adverse event | Patients taking drug not having adverse event | Patients not taking drug having adverse event | Patients not taking drug not having adverse event |
|---|---|---|---|---|---|---|
| Completed suicide | 71.31 | 50.95 | 20 | 65 | 98148 | 34858698 |
FDA Adverse Event Reporting System (Geriatric)
| MedDRA adverse event term | Likelihood ratio | Likelihood ratio threshold | Patients taking drug having adverse event | Patients taking drug not having adverse event | Patients not taking drug having adverse event | Patients not taking drug not having adverse event |
|---|---|---|---|---|---|---|
| Completed suicide | 59.56 | 34.29 | 24 | 235 | 245743 | 79498386 |
FDA Adverse Event Reporting System (Pediatric)
None
Pharmacologic Action:
| Source | Code | Description |
|---|---|---|
| ATC | A09AB03 | ALIMENTARY TRACT AND METABOLISM DIGESTIVES, INCL. ENZYMES DIGESTIVES, INCL. ENZYMES Acid preparations |
| ATC | B05XA13 | BLOOD AND BLOOD FORMING ORGANS BLOOD SUBSTITUTES AND PERFUSION SOLUTIONS I.V. SOLUTION ADDITIVES Electrolyte solutions |
| CHEBI has role | CHEBI:75771 | Mus musculus metabolites |
Drug Use | Suggest Off label Use Form| |View source of the data|
None
🐶 Veterinary Drug Use
None
🐶 Veterinary products
None
Acid dissociation constants calculated using MoKa v3.0.0
None
Orange Book patent data (new drug applications)
None
Orange Book exclusivity data (new drug applications)
None
Bioactivity Summary:
| Target | Class | Pharos | UniProt | Action | Type | Activity value (-log[M]) | Mechanism action | Bioact source | MoA source |
|---|---|---|---|---|---|---|---|---|---|
| Carbonic anhydrase 4 | Enzyme | Ki | 4.05 | CHEMBL |
External reference:
| ID | Source |
|---|---|
| D02057 | KEGG_DRUG |
| 4018214 | VUID |
| N0000146547 | NUI |
| 4018214 | VANDF |
| CHEBI:17883 | CHEBI |
| CHEMBL1231821 | ChEMBL_ID |
| DB13366 | DRUGBANK_ID |
| QTT17582CB | UNII |
| 5486 | RXNORM |
| NOCODE | MMSL |
| 001112 | NDDF |
| 27763000 | SNOMEDCT_US |
| 420502008 | SNOMEDCT_US |
| C0020259 | UMLSCUI |
| D006851 | MESH_DESCRIPTOR_UI |
| CL | PDB_CHEM_ID |
| CLO | PDB_CHEM_ID |
| 313 | PUBCHEM_CID |
Pharmaceutical products:
| Product | Category | Ingredients | NDC | Form | Quantity | Route | Marketing | Label |
|---|---|---|---|---|---|---|---|---|
| EBV/CFS Plus | HUMAN OTC DRUG LABEL | 20 | 43742-1184 | LIQUID | 6 [hp_X] | ORAL | unapproved drug other | 9 sections |